RAPPER: The Radiogenomics of Radiation Toxicity

Clinical Oncology

Volumn 25, Issue 7, 2013, Pages 431-434

  Burnet, N G ^a   Barnett, G C ^a   Elliott, R M ^c   Dearnaley, D P ^c   Pharoah, P D P ^a   Dunning, A M ^a   West, C M L ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RADIOTHERAPY; CLINICAL RESEARCH; EDITORIAL; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IMAGE GUIDED RADIOTHERAPY; INDIVIDUALIZATION; INTENSITY MODULATED RADIATION THERAPY; PRIORITY JOURNAL; RADIOGENOMICS ASSESSMENT OF POLYMORPHISMS FOR PREDICTING THE EFFECTS OF RADIOTHERAPY STUDY; RADIOSENSITIVITY; TOXICITY;

HUMANS; MULTICENTER STUDIES AS TOPIC; NEOPLASMS; POLYMORPHISM, GENETIC; RADIATION INJURIES; RADIATION TOLERANCE; RADIOTHERAPY;

EID: 84878657659     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2013.04.001     Document Type: Editorial

References (30)

1. Norman A., Kagan A.R., Chan S.L. The importance of genetics for the optimization of radiation therapy. A hypothesis. Am J Clin Oncol 1988, 11(1):84-88.
2. Ågren A., Brahme A., Turesson I. Optimization of uncomplicated control for head and neck tumors. Int J Radiat Oncol Biol Phys 1990, 19(4):1077-1085.
3. West C.M., Hendry J.H. Intrinsic radiosensitivity as a predictor of patient response to radiotherapy. Br J Radiol Suppl 1992, 24:146-152.
4. Burnet N.G., Wurm R., Nyman J., Peacock J.H. Normal tissue radiosensitivity - how important is it?. Clin Oncol 1996, 8:25-34.
5. Barnett G.C., West C.M., Dunning A.M., et al. Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nat Rev Cancer 2009, 9:134-142.
6. RAPPER website: [last accessed 08.07.13]. http://www.RAPPER-study.org/.
7. Barnett G.C., Wilkinson J., Moody A.M., et al. Arandomised controlled trial of forward-planned radiotherapy (IMRT) for early breast cancer: baseline characteristics and dosimetry results. Radiother Oncol 2009, 92(1):34-41.
8. Turesson I. Individual variation and dose dependency in the progression rate of skin telangiectasia. Int J Radiat Oncol Biol Phys 1990, 19:1569-1574.
9. Tucker S.L., Turesson I., Thames H.D. Evidence of individual differences in the radiosensitivity of human skin. Eur J Cancer 1992, 28A(11):1783-1791.
10. Bentzen S.M., Overgaard J. Patient-to-patient variability in the expression of radiation-induced normal tissue injury. Semin Radiat Oncol 1994, 4:68-80.
11. Turesson I., Nyman J., Holmberg E., Odén A. Prognostic factors for acute and late skin reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys 1996, 36(5):1065-1075.
12. Burnet N.G., Johansen J., Turesson I., Nyman J., Peacock J.H. Describing patients' normal tissue reactions: concerning the possibility of individualising radiotherapy dose prescriptions based on potential predictive assays of normal tissue radiosensitivity. Steering Committee of the BioMed2 European Union Concerted Action Programme on the Development of Predictive Tests of Normal Tissue Response to Radiation Therapy. Int J Cancer 1998, 79:606-613.
13. Holscher T., Bentzen S.M., Baumann M. Influence of connective tissue diseases on the expression of radiation side effects: a systematic review. Radiother Oncol 2006, 78:123-130.
14. Barnett G.C., De Meerleer G., Gulliford S.L., Sydes M.R., Elliott R.M., Dearnaley D.P. The impact of clinical factors on the development of late radiation toxicity: results from the Medical Research Council RT01 trial (ISRCTN47772397). Clin Oncol 2011, 23(9):613-624.
15. Roberts S.A., Spreadborough A.R., Bulman B., Barber J.B., Evans D.G., Scott D. Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer?. Am J Hum Genet 1999, 65(3):784-794.
16. West C.M., Barnett G.C. Genetics and genomics of radiotherapy toxicity: towards prediction. Genome Med 2011, 3(8):52.
17. Burnet N.G., Nyman J., Turesson I., Wurm R., Yarnold J.R., Peacock J.H. Prediction of normal tissue tolerance to radiotherapy from invitro cellular radiation sensitivity. Lancet 1992, 339:1570-1571.
18. Brock W.A., Tucker S.L., Geara F.B., et al. Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer. Int J Radiat Oncol Biol Phys 1995, 32:1371-1379.
19. Johansen J., Bentzen S.M., Overgaard J., Overgaard M. Relationship between the invitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy. Radiother Oncol 1996, 40:101-109.
20. Peacock J., Ashton A., Bliss J., et al. Cellular radiosensitivity and complication risk after curative radiotherapy. Radiother Oncol 2000, 55:173-178.
21. West C.M., Davidson S.E., Elyan S.A., et al. Lymphocyte radiosensitivity is a significant prognostic factor for morbidity in carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2001, 51(1):10-15.
22. Carlomagno F., Burnet N.G., Turesson I., et al. Comparison of DNA repair protein expression and activities between human fibroblast cell lines with different radiosensitivities. Int J Cancer 2000, 85:845-849.
23. Andreassen C.N., Alsner J., Overgaard M., Sørensen F.B., Overgaard J. Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and ATM - a study based on DNA from formalin fixed paraffin embedded tissue samples. Int J Radiat Biol 2006, 82(8):577-586.
24. Easton D.F., Pooley K.A., Dunning A.M., et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007, 447:1087-1093.
25. West C., Rosenstein B.S., Alsner J., et al. Establishment of a Radiogenomics Consortium. Int J Radiat Oncol Biol Phys 2010, 76(5):1295-1296.
26. Kerns S.L., Stock R., Stone N., et al. A2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 2013, 85(1):e21-e28.
27. Barnett G.C., Coles C.E., Burnet N.G., et al. No association between SNPs regulating TGF-β1 secretion and late radiotherapy toxicity to the breast: results from the RAPPER study. Radiother Oncol 2010, 97(1):9-14.
28. Barnett G.C., Elliott R.M., Alsner J., et al. on behalf of the Radiogenomics Consortium. Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity. Radiother Oncol 2012, 105(3):289-295.
29. Barnett G.C., Coles C.E., Elliott R.M., et al. Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study. Lancet Oncol 2012, 13(1):65-77.
30. Coles C.E., Faivre-Finn C. Radiotherapy research trials in the UK: secrets of success. Clin Oncol (R Coll Radiol) 2012, 24(4):229-231.